IL-12 and viral infections

Cytokine and Growth Factor Reviews

Volumn 9, Issue 3-4, 1998, Pages 277-285

  Komastu, Takashi ^a,b   Ireland, Derek D C ^a   Reiss, Carol Shoshkes ^a  

^a NEW YORK UNIVERSITY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Acquired immunity; Innate immunity; Interleukin 12; Signal transduction; Viral infection

Indexed keywords

INTERLEUKIN 12;

ANIMAL; ANTIGEN PRESENTING CELL; ASTROCYTE; CELLULAR IMMUNITY; DENDRITIC CELL; HUMAN; IMMUNOLOGY; MACROPHAGE; NONHUMAN; PHYSIOLOGY; REVIEW; VIRUS IMMUNITY; VIRUS INFECTION;

ANIMALS; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-12; VIRUS DISEASES;

EID: 0344267644     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(98)00017-3     Document Type: Review

References (75)

1. Levy DE. The house that Jak/STAT built. Cytokine and Growth Factor Rev 1997, 8, 81-90.
2. O'Shea JJ. Jaks, Stats, cytokine signal transduction, and immunoregulation: are we there yet? Immunity 1997, 7, 1-11.
3. Ihle JN. Cytokine receptor signaling. Nature 1995, 377, 591-594.
4. Relton JK, Neuberger TJ, Bendele AM, Martin D, Russell D. Cytokines: neurotoxicity and neuroprotection. In Bar PR, Beal MF, eds. Neuroprotection in CNS Diseases. NY, Dekker, 1997, 225-241.
5. Ransahoff RM, Hamilton TA, Tani M, Stoler MH, Schick HS, Major JA, Estes ML, Thomas DM, Tuohy VK. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in EAE. FASEB 1993, 7, 592-600.
6. Fontana, Constam D, Frei K, Koedel U, Pfister W, Weller M. Cytokines and defense against CNS infection. Cytokines and the CNS. CRC Press, 1996, 188-219.
7. Irani DN, Lin K-I, Griffin D. Regulation of brain-derived T cells during acute CNS inflammation. Immunol 1997, 158, 2318-2326.
8. Breder CD, Tsujimoto M, Terano Y, Scott DW, Saper CF. Distribution and characterization of TNF-α-like immunoreactivity in the murine CNS. J Comp Neuro 1993, 337, 543-567.
9. Ilyin SE, Plata-Salaman CR. In vivo regulation of the IL-1β system and TNF-α mRNAs in specific brain regions. Biochem and Biophys Res Comm 1996, 227, 861-867.
10. Probert L, Akassoglou K, Kassiotis G, Pasparakis M, Alexopoulou L, Kollias G. TNF-α transgenic and knockout models of CNS inflammation and degeneration. J Neurolmmunol 1997, 72, 137-141.
11. Wallach D. Suicide by order: some open questions about the cell killing activities of the TNF-α ligand and receptor families. Cytokine and Growth Factor Rev 1996, 7, 211-221.
12. Wisniewski H-G, Hua JC, Poppers DM, Naime D, Vilcek J, Cronstein BN. TNF-IL-1-inducible protein TSG-6 potentiates plasmin inhibition by inter-α-inhibitor and exerts strong anti-inflammatory effect in vivo. J Immunol 1996, 156, 1609-1616.
13. Bruce AJ, Bolling W, Kindy MS, Peschon J, Kraemer PJ, Carpenter MK, Holtsberg FW, Mattson MP. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF-R. Nat Med 1996, 2, 788-794.
14. Wolf SF, Diebarth S, Sypek J. IL-12 a key modulator of immune function. Stem Cell 1994, 12, 154-168.
15. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM. Development of CD4 T cells through IL-12 produced by Listeria-induced macrophages. Science 1993, 260, 547-551.
16. Constantinuescu C, Frei K, Malipiero U, Rostami A, Fontana A. Astrocytes and microglia produce IL-12. Ann N York Acad Sci 1996, 795, 328-333.
17. Stalder AK, Pagenstecher A, Yu NC, Kincaid C, Chiang CS, Hobbs MV, Bloom FE, Campbell IL. Lipopolysaccharide-induced IL-12 expression in the CNS and cultured astrocytes and microglia. J Immunol 1997, 159, 1344-1351.
18. Chan SH, Perussia B, Gupta JW, Kobayashi M, Pospisil M, Young HA, Wolf S, Young D, Clark SC, Trinchieri G. Induction of IFN-γ production by NK stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 1991, 173, 869-879.
19. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trinchieri G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989, 170, 827-846.
20. Chehimi A, Valiante N, D'Andrea A, Rengaraju M, Rosado Z, Kobayashi M, Perussia B, Wolf SF, Starr SE, Trinchieri G. Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells. Eur J Immunol 1993, 23, 1826-1830.
21. Orange JS, Wolf SF, Biron CA. Effects of IL-12 on the response and susceptibility to experimental viral infections. J Immunol 1994, 152, 1253-1264.
22. Orange JS, Salazar-Mather TP, Opal SM, Spencer RL, Miller AH, McEwen BS, Biron CA. Mechanism of interleukin-12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids. J Exp Med 1995, 181, 901-914.
23. Komatsu T, Bi Z, Reiss CS. IFN-γ induced NOS-1 activity inhibits viral replication in neurons. J Neurolmmunol 1996, 68, 101-108.
24. Allavena P, Paganin C, Zhou D, Bianchi G, Sozzani S, Mantovani A. Interleukin-12 is chemotactic for natural killer cells and stimulates their interaction with vascular endothelium. Blood 1994, 84, 2261-2268.
25. Williamson JS, Sykes KC, Stohlman SA. Characterization of brain-infiltrating mononuclear cells during infection with mouse hepatitis virus strain JHM. J NeuroImmunol 1991, 32, 199-207.
26. Christian AY, Barna M, Bi Z, Reiss CS. Host immune response to vesicular stomatitis virus infection of the central nervous system in C57BI/6 mice. Viral Immunol 1996, 9, 195-205.
27. Biron CA, Byron KS, Sullivan JL. Severe herpesvirus infections in an adolescent without natural killer cells. N Eng J Med 1989, 320, 1731-1735.
28. Welsh RM, Brubaker JO, Vargas-Cortes M, O'Donnell CL. Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function. J Exp Med 1991, 173, 1053-1063.
29. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM. Development of Th1 CD4 T cells through IL-12 produced by Listeria-induced macrophages. Science 1993, 260, 547-549.
30. Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G, Romagnani S. Natural killer stimulatory factor (interleukin 12) induces T helper type-1 (Th1)-specific immune responses and inhibits the development of IL-4-producing cells. J Exp Med 1993, 177, 1199-1204.
31. Kiniwa M, Gately M, Gubler U, Chizzonite R, Fargeas C, Delespesse G. Recombinant interleukin-12 suppresses the synthesis of immunoglobulin E by interleukin-4 stimulated human lymphocytes. J Clin Invest 1992, 90, 262-266.
32. Morris SC, Madden KB, Adamovicz JJ, Gause WC, Hubbard BR, Gately MK, Finkelman FD. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J Immunol 1994, 152, 1047-1056.
33. McKnight AJ, Zimmer GJ, Fogelman I, Wolf SF, Abbas AK. Effects of IL-12 on helper T cell-dependent immune responses in vivo. J Immunol 1994, 152, 2172-2179.
34. Williamson E, Garside P, Bradley JA, More IA, Mowat AM. Neutralizing IL-12 during induction of murine acute graft-versus-host disease polarizes and cytokine profile toward a Th2-type alloimmune response and confers long term protection from disease. J Immunol 1997, 159, 1208-1215.
35. Magram J, Connaughton SE, Warrier RR, Carvajal D, Wu C, Ferrante J, Steward C, Sarmiento U, Faherty DA, Gately MK. IL-12 deficient mice are defective in IFN-gamma production and type 1 cytokine responses. Immunity 1996, 4, 471.
36. Piccotti JR, Li K, Chan SY, Ferrante J, Magram J, Eichwald EJ, Bishop DK. Alloantigen-reactive TH1 development in IL-12 deficient mice. J Immunol 1998, 160, 1132-1138.
37. Schijns VE, Haagmans BL, Wierda CM, Kruithof B, Heijnen IA, Alber G, Horzinek MC. Mice lacking IL-12 develop polarized Th1 cells during viral infection. J Immunol 1998, 160, 3958-3964.
38. Gillespie MT, Horwood NJ. IL-8: prespectives on the newest interleukin. Cytokine and Growth Factor Rev 1998, 9, 109-116.
39. Chen L, Chen D, Block E, O'Donnell M, Kufe DW, Clinton SK. Eradication of murine bladder carcinoma by intratrumor injection of a bicistronic adenoviral vector carrying cDNAs of the IL-12 heterodimer and its inhibition by the IL-12 p40 subunit homodimer. J Immunol 1997, 159, 351-359.
40. Coughlin CM, Wysocka M, Trinchieri G, Lee WMF. The effects of IL-12 desensitization on the antitumor efficacy of rIL-12. Cancer Res 1997, 57, 2460-2467.
41. Leonard JP, Waldberger KE, Goldman NS SJ. Prevention of EAE by antibodies against IL-12. J Exp Med 1995, 181, 368-381.
42. Gately MK, Renzetti LM, Magram J, Stern AS, Adorini L, Gubler U, Presky DH. IL-12/IL-12R system: role in normal and pathologic immune responses. Ann Rev Immunol 1998, 16, 495-521.
43. Chua AO, Wilkinson VL, Presky D, Gubler U. Cloning and characterization of a mouse IL-12R β component. J Immunol 1995, 155, 4286-4294.
44. Szabo SJ, Dighe AS, Gubler U, Murphy KM. Regulation of the IL-12R β2 subunit expression in developing Th1 and Th2 cells. J Exp Med 1997, 185, 817-824.
45. Wu C-Y, Warrier RR, Wang X, Presky DH, Gately MK. Regulation of IL-12Rβ1 chain expression and IL-12 binding by human PBMC. European J Immunol 1997, 27, 147-154.
46. Rogge L, Barberis-Maino L, Biffi M, Passini N, Presky DH, Gubler U, Sinigaglia F. Selective expression of IL-12R by human Th1 cells. J Exp Med 1997, 185, 825-831.
47. Showe LC, Wysocka M, Wang B, Line-man-Williams D, Peritt D, Showe MK, Trinchieri G. Structure of the mouse IL-12Rb1 chain and regulation of its expression in BCG/LPS treated mice. In IL-12: cellular and molecular immunology of an important regulatory cytokine. Ann N York Acad Sci 1996, 795, 413-415.
48. Jacobson NG, Szabo SJ, Weber-Nordt RM, Zhong Z, Schreiber RD, Darnell JE, Murphy KM. IL-12 signaling in Th1 cells involves tyrosine phosphorylation of Stat 3 and 4. J Exp Med 1995, 181, 1755-1762.
49. Szabo SJ, Jacobson NG, Dighe AS, Gubler U, Murphy KM. Development commitment to the TH2 lineage by extinction of IL-12 signaling. Immunity 1995, 2, 665-675.
50. Leonard WJ, O'Shea JJ. Jaks STATs: Biological implication. Ann Rev Immunol 1998, 16, 295-322.
51. Kaplan MH, Sun YL, Hoey T, Grusby MJ. Impaired IL-12 responses and enhanced development of Th2 cells in Stat-4-deficient mice. Nature 1996, 382, 174-177.
52. Kaplan MH, Schindler U, Smiley ST, Grusby MJ. Stat6 is required for mediating responses to IL-4 and for the development of the Th2 cells. Immunity 1996, 4, 313-319.
53. Parganas E, Wang D, Stravopodis D, Topham DJ, Marine JC, Teglund S, Vanin EF, Bodner S, Colamonici OR, van Deursen JM, Grosveld G, Ihle JN. Jak2 is essential for signaling through a variety of cytokine receptors. Cell 1998, 93, 385-395.
54. Neubauer H, Cumano A, Muller M, Wu H, Huffstadt U, Pfeffer K. Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell 1998, 93, 397-409.
55. Coutelier JP, Broeck JV, Wolf SF. Interleukin-12 gene expression after viral infection in the mouse. J Virol 1995, 69, 1955-1958.
56. Kanangat S, Thomas J, Grangappa S, Babu JS, Rouse BT. Herpes simplex virus type 1-mediated up-regulation of IL-12 (p40) mRMA expression. Implications in immunopathogenesis and protection. J Immunol 1996, 156, 1110-1116.
57. Barna M, Komatsu T, Reiss CS. Cytokine-induced activation of type III nitric oxide synthase in astrocytes following a neurotropic viral infection in the CNS. Virol 1996, 233, 331-343.
58. Ozmen L, Aguet M, Trinchieri G, Garotta G. The in vivo antiviral activity of IL-12 is mediated by IFN-γ. J Virol 1998, 69, 8147-8150.
59. Monteiro JM, Harvey C, Trinchieri G. Role of interleukin-12 in primary influenza virus infection. J Virol 1998, 72, 4825-4831.
60. Bi Z, Barna M, Komatsu T, Reiss CS. Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity. J Virol 1995, 69, 6466-6471.
61. Bi Z, Quandt P, Komatsu T, Barna M, Reiss CS. IL-12 promotes enhanced recovery from vesicular stomatitis virus infection of the central nervous system. J Immunol 1995, 155, 5684-5689.
62. Komatsu T, Barna M, Reiss CS. IL-12 promotes recovery from viral encephalitis. Viral Immunol 1997, 10, 35-47.
63. Komatsu T, Reiss CS. IFN-γ is not required in the IL-12 response to VSV infection of the olfactory bulb. J Immunol 1997, 159, 3444-3452.
64. Reiss CS, Komatsu T. Does nitric oxide play a critical role in viral infections? J Virol 1998, 72, 4547-4551.
65. Schijns V, Wierda CMH, Hoeij MV, Horzinek MC. Exacerbated viral hepatitis in IFN-γ receptor-deficient mice is not suppressed by IL-12. J Immunol 1996, 157, 815-821.
66. Lane TE, Paoletti AD, Buchmeier MJ. Dissociation between in vitro and in vivo effects of nitric oxide on a neurtropic murine coronavirus. J Virol 1997, 71, 2202-2210.
67. Gazzinelli RT, Giese NA, Morse III HC. In vivo treatment with interleukin-12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS). J Exp Med 1994, 180, 2199-2208.
68. Tsuji T, Hamajima K, Fukushima J, Xin K-Q, Ishii N, Aoki I, Ishigatsubo Y, Tani K, Kawamoto S, Nitta Y, Miyazaki J, Koff WC, Okubo T, Okuda K. Enhancement of cell-mediated immunity against HIV-1 induced by coin-oculation of plasmic-encoded HIV-1 antigen with plasmid expressing IL-12. J Immunol 1997, 158, 4008-4013.
69. Cavanaugh VJ, Guidotti LG, Chisari FV. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice. J Virol 1997, 71, 3236-3243.
70. Schijns, VECJ, Haagmas BL, Horzinek MC. IL-12 stimulates an antiviral type 1 cytokine response but lacks adjuvant activity in IFN-γ-receptor deficient mice. J Immunol 1995, 155, 2525-2532.
71. Orange JS, Wang B, Terhorst C, Biron CA. Requirement for natural killer cell-produced interferon-γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by Interleukin-12 administration. J Exp Med 1995, 182, 1045-1056.
72. Carr JA, Rogerson J, Mulqueen MJ, Roberts NA, Booth RFG. Interleukin-12 exhibits potent antiviral activity in experimental herpesvirus infections. J Virol 1997, 71, 7799-7803.
73. Matsuo R, Kobayashi M, Herndon DN, Pollard RB, Suzuki F. Interleukin-12 protects thermally injured mice from herpes simplex virus type I infection. J Leuk Biol 1996, 59, 623-630.
74. Klein JL, Fickenscher H, Holliday JE, Biesinger B, Fleckenstein B. Herpesvirus saimiri immortalized γδ T cell line activated by IL-12. J Immunol 1996, 156, 2754-2760.
75. Karp CL, Wysocka M, Whal LM, Ahern JM, Cuomo PJ, Sherry B, Trinchieri G, Griffin DE. Mechanism of suppression of cell mediated immunity by measles virus. Science 1996, 273, 228-231.